Navigation Links
Terumo Americas Holding Acquires Onset Medical Corporation, a Leader in Innovative Sheath Technology Designed for Multiple, Minimally Invasive Clinical Applications
Date:1/16/2012

SOMERSET, N.J., Jan. 16, 2012 /PRNewswire/ -- Terumo Americas Holding, Inc. (TAH), a U.S. subsidiary of Japan's Terumo Corporation, one of the world's leading medical device manufacturers with $4 billion in sales and operations in more than 160 nations, today announced that it has acquired Onset Medical Corporation ("Onset"), an innovative medical device company located in Irvine, CA, that focuses on developing first-in-class access sheath technology designed for multiple, minimally invasive clinical applications in cardiology and urology.

Using its proprietary Controlled Deployment Technology (CDT) platform, Onset has developed the smallest sheath profiles with the largest internal diameters of any available access sheath to protect against unnecessary access site or arterial trauma for the patient. Onset's Associates will join with TAH subsidiary Terumo Medical Corporation as part of its Terumo Interventional Systems (TIS) business unit, where the CDT platform will complement TIS' complete product line of industry leading entry site management and lesion access technologies.

Terumo customers will have access to Onset's complete product lines.  The SoloPath™ Balloon Expandable Transfemoral and Transseptal Catheters' expandable and collapsable sheath technology allows TIS to enter the global structural heart and aneurysmal repair markets, providing an access platform for complex, large-bore procedures including Transcatheter Aortic Valve Implantation (TAVI), Thoracic Endovascular Aortic/Aneurysm Repair (TVAR) and Endovascular Aneurysm/Aortic Repair (EVAR).  The Pathway™ Balloon Expandable PCNL Sheath and Pathway™ Balloon Expandable Ureteral Access Sheath provide physicians with a one-step option for performing procedures such as Percutaneous Nephrolithotomy in the removal of large renal calculi (kidney stones).

"We welcome Onset to the Terumo family and look forward to providing our customers with current and
'/>"/>

SOURCE Terumo Americas Holding, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September
2. Terumo Heart Reports Summary of DuraHeart(TM) LVAS Clinical Trial Results
3. Terumo Heart Summarizes Results of DuraHeart(TM) LVAS Implants
4. Terumo Heart Obtains IRB Approval from the University of Michigan to Initiate DuraHeart(TM) Left Ventricular Assist System U.S. Pivotal Trial
5. Terumo Heart, Inc. Reports Clinical Progress in the DuraHeart(TM) U.S. Pivotal Trial as NewYork-Presbyterian Hospital/Columbia University Medical Center Implants First Patient
6. Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives the DuraHeart(TM) Left Ventricular Assist System
7. Terumo Cardiovascular Systems Initiates U.S. Clinical Trial for Anaconda(TM) AAA Stent Graft System
8. Terumo to Sponsor Presentations on Key Issues in Cardiac and Vascular Surgery at Society of Thoracic Surgeons Annual Meeting
9. Terumo To Simultaneously Evaluate Misago Self-Expanding Stent System in the United States and Japan
10. VirtuoSaph® Plus Endoscopic Vessel Harvesting System from Terumo Continues the Advancement of the Minimally Invasive Technique for Coronary and Peripheral Artery Bypass Grafting
11. Terumo Cardiovascular Systems Reaches Agreement on Terms of Consent Decree With FDA Regarding Quality System Improvements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... June 19, 2013   Voices Against Brain Cancer ... cure for brain cancer, today announced that it has ... support the clinical investigation of Toca 511 & Toca ... glioma brain cancer (Grade 3 or Grade 4).  Tocagen ... for advanced cancer, with an initial focus on brain ...
(Date:6/19/2013)...   Nektar Therapeutics (Nasdaq: NKTR ) ... (HAL) study for NKTR-181, a first-in-class, opioid analgesic ... This slow rate of entry is designed to reduce the ... to current opioid analgesics. 1 In the study data ... placebo in "drug liking" and "feeling high" scores and had ...
(Date:6/19/2013)... ZIONA, Israel , June 19, ... that results from a phase I study in volunteers, ... advanced Parkinson,s patients, of ND0612, were presented at the ... ND0612 is a proprietary levodopa/carbidopa liquid drug formula under ... patch that would maintain constant levodopa plasma concentrations. ...
Breaking Medicine Technology:Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 2Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 3Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 2Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 3Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 4Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 5Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 6Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 7Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 8Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 9NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 2NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 3NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 4NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 5NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 6
(Date:6/19/2013)... 19, 2013 Brightree LLC , ... software solutions for the post-acute care industry, has been ranked ... the Healthcare Informatics 100 (HCI 100) list. This ... the U.S. in terms of revenue during the last fiscal ... rate of 85% annually, and the company has built its ...
(Date:6/19/2013)... AZ (PRWEB) June 19, 2013 Guests at ... healthy, wealthy and wise even if they don’t go to ... does require some early thought. , Crafty ... when they take advantage of the pet-friendly Scottsdale Paradise Valley ... Package . With at least 14 days advance notice, guests ...
(Date:6/19/2013)... Boca Raton, FL (PRWEB) June 19, 2013 ... spoke about the positive changes and growth that has occurred ... his nationwide travel club. , Shuman said, "Travel Services has ... program to heights beyond belief. Membership is up, even ... agents to meet the demands of members." , Having been ...
(Date:6/19/2013)... Amerinet, Inc, a leading national ... to help Pacific Medical Centers implement a comprehensive ... than 17 percent over the organization’s previous clinical ... economies of scale and process standardization are two ... multi-site providers,” said Shawn Padilla, director of supply ...
(Date:6/19/2013)... lateral sclerosis (ALS), also known as Lou Gehrig,s Disease, ... classified into four distinct stages, report pathologists with the ... in the Annals of Neurology . This post-mortem ... for the first time, how the fatal degenerative disease ... nervous system to other regions of brain and spinal ...
Breaking Medicine News(10 mins):Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 2Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 3Health News:Plan Ahead and Save Big With New Deal From Residence Inn Scottsdale Paradise Valley 2Health News:Plan Ahead and Save Big With New Deal From Residence Inn Scottsdale Paradise Valley 3Health News:Plan Ahead and Save Big With New Deal From Residence Inn Scottsdale Paradise Valley 4Health News:Former Owner Eric Shuman Endorses New Owners and Changes Made in Last Year Since Shuman Sold Travel Services Center at Member Conference 2Health News:Amerinet Partners with ARAMARK Healthcare Technologies to Help Pacific Medical Centers Save 17 Percent and Better Manage System-Wide Equipment Program 2Health News:Staging system in ALS shows potential tracks of disease progression, Penn study finds 2
... is a Wholly Owned Subsidiary of Shamir, KIBBUTZ ... SHMR ) ("Shamir"), a leading provider of innovative,products ... it has,signed an agreement yesterday, June 30, 2008, pursuant ... ("Altra") from its minority,shareholder. Prior to this transaction, Shamir ...
... Conn., July 1 UTC Power, a United,Technologies Corp. ... supply St.,Helena Hospital in California,s Napa Valley with its ... will be in full,production in the summer of 2009., ... hospital and,part of Adventist Health, a not-for-profit health care ...
... July 1 Opus Healthcare Solutions, Inc.,a ... has named Ray,Bechtold, CPA, as controller. Based ... responsible for overseeing all accounting and financial,administrative ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080325/LATU040LOGO ), Bechtold joined ...
... RGEN ) announced today that Dr. Alfred L. ... Dr. Goldberg is currently a Professor of,Cell Biology at ... in,particular for elucidating the structure and function of the ... destroyed in,cells. In addition, he has made major contributions ...
... pain. This was the result of the analysis ... her colleagues and published in the current edition ... Int, 2008; 105[24]: 441-8). , http://www.aerzteblatt.de/v4/archiv/pdf.asp?id=60552 ... more than 8000 private persons in the course ...
... staying asleep increase as women go through menopause ... Waking up earlier than planned also increases through ... The study is published in the July 1 ... "Sleep difficulties, especially problems staying asleep, are relatively ...
Cached Medicine News:Health News:Shamir Optical Industry Purchases Remaining 49% of Altra Trading GmbH 2Health News:Shamir Optical Industry Purchases Remaining 49% of Altra Trading GmbH 3Health News:St. Helena's Hospital Orders New Model 400kW Fuel Cell From UTC Power 2Health News:Opus Healthcare Solutions Names Ray Bechtold as Controller 2Health News:Repligen Elects Alfred L. Goldberg, Ph.D. to the Board of Directors 2Health News:Repligen Elects Alfred L. Goldberg, Ph.D. to the Board of Directors 3Health News:Sleep problems associated with menopause vary among ethnic groups 2
It is designed for rigid skeletal fixation. These pins are constructed of stainless steel and can be removed for sterilization and reuse....
It is designed for rigid skeletal fixation. These pins are constructed of stainless steel and can be removed for sterilization and reuse....
It is designed for rigid skeletal fixation. These pins are constructed of stainless steel and can be removed for sterilization and reuse....
... designed for rigid skeletal fixation, ... freedom in positioning the fixation ... fixation is designed for the ... positions. Craniotomies can be performed ...
Medicine Products: